share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Sulzberger Gabrielle

SEC ·  Aug 21 04:24

Summary by Futu AI

Gabrielle Sulzberger, associated with Eli Lilly and Co (LLY), completed a purchase of 11 shares of common stock on August 19, 2024. The transaction was carried out at a price of $921.81 per share, resulting in a total investment of $10,139.91. Following this acquisition, Sulzberger's direct holdings in the company increased to a total of 2,176 shares. The transaction is reported as a direct ownership type and is classified as a grant, award, or other acquisition.
Gabrielle Sulzberger, associated with Eli Lilly and Co (LLY), completed a purchase of 11 shares of common stock on August 19, 2024. The transaction was carried out at a price of $921.81 per share, resulting in a total investment of $10,139.91. Following this acquisition, Sulzberger's direct holdings in the company increased to a total of 2,176 shares. The transaction is reported as a direct ownership type and is classified as a grant, award, or other acquisition.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.